Market Research Industry Reports

China Resources Pharmaceutical Group Ltd (20) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise chemical medicines, TCMs, biologics, and health food and traditional Chinese medicine, and nutritional products. CR Pharma offers products in forms of oral solid dosage, large infusion bags, powder vials, oral liquid dosage, injections, and topical preparations. The company markets its products through logistics, wholesale, retail and supply chain services in different provinces across China. CR Pharma is headquartered in Hong Kong.

China Resources Pharmaceutical Group Ltd (20) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
China Resources Pharmaceutical Enters into Agreement with Fujifilm 12
China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 1
Pfizer and CR Saike Pharma Enter into Distribution Agreement 14
China Resources Zizhu Enters into Agreement with Uni-Bio Science 15
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 16
China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 17
China Resources Sanjiu Medical To Form Joint Venture 18
Licensing Agreements 19
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 19
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 20
Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 21
Equity Offering 22
China Resources Pharma Raises USD1.8 Million in IPO 22
Acquisition 24
China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 24
China Resources Sanjiu Medical to Acquire Kunming Shenghuo Pharmaceutical for USD28Million 25
China Resources Double Crane Pharma to Acquire China Resources Saike Pharma for USD578.6 Million 26
The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lans Intl Medicine Investment 27
China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For US$94 Million 28
China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For US$95 Million 29
China Resources Pharmaceutical Group Ltd - Key Competitors 0
China Resources Pharmaceutical Group Ltd - Key Employees 1
China Resources Pharmaceutical Group Ltd - Locations And Subsidiaries 2
Head Office 2
Other Locations & Subsidiaries 2
Recent Developments 4
Financial Announcements 4
Aug 24, 2017: China Resources Pharmaceutical Group: Interim Results Announcement For The Six Months Ended 0 June 2017 4
Corporate Communications 8
Aug 07, 2017: China Resources Pharmaceutical: Appointment of Independent Non-executive Director 8
Appendix 9
Methodology 9
About GlobalData 9
Contact Us 9
Disclaimer 9

List Of Tables

List of Tables
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Resources Pharmaceutical Enters into Agreement with Fujifilm 12
China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 13
Pfizer and CR Saike Pharma Enter into Distribution Agreement 14
China Resources Zizhu Enters into Agreement with Uni-Bio Science 15
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 16
China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 17
China Resources Sanjiu Medical To Form Joint Venture 18
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 19
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 20
Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 21
China Resources Pharma Raises USD1.8 Million in IPO 22
China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 24
China Resources Sanjiu Medical to Acquire Kunming Shenghuo Pharmaceutical for USD283 Million 25
China Resources Double Crane Pharma to Acquire China Resources Saike Pharma for USD578.6 Million 26
The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lans Intl Medicine Investment 27
China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For US$94 Million 28
China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For US$95 Million 29
China Resources Pharmaceutical Group Ltd, Key Competitors 30
China Resources Pharmaceutical Group Ltd, Key Employees 31
China Resources Pharmaceutical Group Ltd, Other Locations 32
China Resources Pharmaceutical Group Ltd, Subsidiaries 32

List Of Figures

List of Figures
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Wealth in China: HNW Investors 2018

Wealth in China: HNW Investors 2018 Wealth in China: HNW Investors 2018 , report analyzes the investing preferences and portfolio allocation of Chinese HNW investors. It is based on our proprietary Global

USD 3450View Report

China Trauma Fixation Market Outlook to 2025

China Trauma Fixation Market Outlook to 2025GlobalDatas new report, China Trauma Fixation Market Outlook to 2025, provides key market data on the China Trauma Fixation market. The report provides value,

USD 4995View Report

Lippo China Resources Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Lippo China Resources Limited Company Profile is a detailed strategic and analytical report on Lippo China Resources Limited. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

China Resources Wandong Medical Equipment Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

China Resources Wandong Medical Equipment Co, Ltd Company Profile is a detailed strategic and analytical report on China Resources Wandong Medical Equipment Co, Ltd. The 2018 version of the report

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Feb 2018
No. of Pages :39
Country :Hong Kong
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube